
metaBIX Biotech
AI-driven environmental pathogen detection with easy-to-use sampling devices and risk assessment reports.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | $500k | Support Program | |
Total Funding | 000k |
Related Content
metaBIX Biotech specializes in developing methods to test environmental samples for the presence of pathogens, utilizing advanced Artificial Intelligence and data collection techniques. The company serves industries that require stringent environmental monitoring, such as healthcare, agriculture, and manufacturing. Operating in the environmental biotechnology market, metaBIX Biotech's business model revolves around providing comprehensive solutions that include proprietary sampling devices and software. These devices are designed to collect air, water, and soil samples autonomously and reliably, ensuring low cost and no cross-contamination. The collected data is then processed by their AI-driven software, which generates easy-to-understand risk assessment reports. These reports help professionals make quick and efficient decisions to mitigate risks. The company generates revenue through the sale of its sampling devices and software subscriptions, offering a complete package for environmental monitoring.
Keywords: AI-driven, pathogen detection, environmental sampling, risk assessment, healthcare, agriculture, manufacturing, biotechnology, autonomous devices, data analytics.